FT Pharma Pricing and Value Summit

September 26 2019

New York , United States

The pharmaceutical pricing and market access landscape is being transformed by a host of factors. Value-based pricing is making the transition from concept to reality but more clarity is needed on what it means and how it works for different stakeholders. Revolutionary therapies with innovative pricing models are entering the market but at the same time decision-makers at pharma companies are being asked to defend pricing strategies for established products. Meanwhile, much of the US government's blueprint to lower drug prices is still in the works and yet to be enacted.

The FT Pharma Pricing and Value Summit will explore the future of drug pricing from a balanced perspective. How could the rebate system evolve? Will new powers for Medicare Part D to negotiate drug prices really make a difference to patients? What global factors could change the pricing and market access landscape in the US?

@FT

Event Details

Country

Year

Subscribe by email